Södergren, Anna http://orcid.org/0000-0002-7436-7900
Askling, Johan
Bengtsson, Karin
Forsblad-d’Elia, Helena
Jernberg, Tomas
Lindström, Ulf
Ljung, Lotta
Mantel, Ängla
Jacobsson, Lennart T. H.
Funding for this research was provided by:
AntiReumatisk Terapi I Sverige
Knut och Alice Wallenbergs Stiftelse
Article History
Received: 13 June 2020
Revised: 13 August 2020
Accepted: 18 August 2020
First Online: 26 August 2020
Compliance with ethical standards
:
: Karolinska Institutet had research agreements with Abbvie, BMS, MSD, Pfizer, Roche, Astra-Zeneca, Eli Lilly, Samsung Bioepis, and UCB, mainly in the context of safety monitoring of biologics via ARTIS/The Swedish Biologics Register. For these, JA has been principal investigator. None of the other co-authors has any conflict of interest.
: The study was conducted in accordance with the principles outlined in the Declaration of Helsinki and principles of Good Clinical Practice (GCP). The study protocol was approved by the Regional Ethics Committee in Stockholm, Sweden (registration number 2015/1844-31/2).
: Not applicable.
: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.